- Zoom AI Companion adapts to users’ personal work habits through model customization and retrieval–augmented generation powered by NVIDIA technology
- Zoom’s federated AI stack expands with NVIDIA [...] Read more »
WeRide Announces CEO’s Voluntary Lock-Up to Reinforce Long-Term Commitment as Company Launches Hong Kong IPO
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) — WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD), a global leader in autonomous driving technology, today announced that Dr. Tony Han, Founder, [...] Read more »
Lantronix Edge AI Technology Powers Sightline’s New AI-Driven Video Processor for Mission-Critical Drone Applications
IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Read more »
StepStone Group Opens Office in Riyadh
- Deepens Relationship with Longstanding Clients in the Kingdom
- Establishes Formal Presence in the Middle East
RIYADH, Saudi Arabia and NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) [...] Read more »
SINTX Technologies erhält FDA-Zulassung für SINAPTIC® Fuß- und Sprunggelenk-Implantatsystem
Das von der FDA zugelassene und in den USA hergestellte Implantatsystem positioniert SINTX für den Eintritt in den milliardenschweren US–Markt
SALT LAKE CITY, Utah, Oct. 20, [...] Read more »
SINTX Technologies Recebe Autorização da FDA para Sistema de Implantes de Pé e Tornozelo SINAPTIC®
A FDA liberou o sistema de implante fabricado nos EUA, posicionando a SINTX para entrar no mercado bilionário do país
SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE [...] Read more »
La FDA autorise le système d’implant de pied et de cheville SINAPTIC® de SINTX Technologies
Fabriqué aux États–Unis et désormais approuvé par la FDA, ce système d’implant conçu par SINTX s’ouvre les portes d’un marché américain [...] Read more »
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion–dollar U.S. market
SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) — SINTX [...] Read more »
UPDATE: SINTX stärkt sein Portfolio zur Infektionsprävention mit einem neu zugelassenen US-Patent, das einen adressierbaren Markt für Antipathogene im Wert von 30 Milliarden US-Dollar abdeckt
Neues US–Patent stärkt Wettbewerbsvorteil und ermöglicht umfassendere Lizenzierungs– und Produktmöglichkeiten in wichtigen Märkten
SALT LAKE CITY, Utah, [...] Read more »
ATUALIZAÇÃO: SINTX Fortalece Portfólio de Prevenção de Infecções com a Recente Patente nos EUA que Abrange um Mercado de US $30 bilhões Endereçável Antipatogênico
Nova patente dos EUA reforça a vantagem competitiva e permite oportunidades mais amplas de licenciamento e produtos nos principais mercados
SALT LAKE CITY, Utah, Oct. 16, 2025 [...] Read more »